Celebrities like Oprah Winfrey are touting it. People are microdosing it. And, in the midst of a national shortage of key ...

A new breast cancer drug has received quick federal approval after a clinical trial showed it could more than double the time before a common type of breast cancer recurrence worsens.

Dividend announcements are not available.

Consisting of five separate booklets, the World Drug Report 2022 provides an in-depth analysis of global drug markets and examines the nexus between drugs and the environment within the bigger picture ...